CIK 0000907654 · Non-accelerated filer<br>Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 363855489
- Phone
- 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $20,653,308
- in 17 filings, $20.2M under 10b5-1 plans
Net −$20,653,308. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
- Quinlan Paul T −$1.7M General Counsel sold 40% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-05 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +5,000 | $3.41 | $17K | 1,676,903 |
| 2024-07-03 | JANUS HENDERSON GROUP PLC 10% owner | Purchase | +166,042 | $3.55 | $590K | 1,648,577 |
| 2024-01-30 | Ma-Weaver Jacob Director | Grant or award · Stock option (right to buy) | +6,000 | 6,000 | ||
| 2024-01-30 | Hove Anders D Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2024-01-30 | MITCHELL DANIEL J Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2024-01-30 | Flynn James P Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2024-01-30 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2024-01-30 | Grais Linda Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2024-01-30 | Woosley Raymond L. Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2022-12-16 | Funicular Funds, LP 10% owner | Option exercise | +1,420,000 | $2.50 | $3.5M | 4,000,452 |
| 2022-12-16 | Funicular Funds, LP 10% owner | Option exercise · Put Option | −14,200 | 30,000 | ||
| 2022-12-16 | Funicular Funds, LP 10% owner | Other disposition · Put Option | −300 | 0 | ||
| 2022-12-15 | Woosley Raymond L. Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2022-12-15 | MITCHELL DANIEL J Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2022-12-15 | Hove Anders D Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2022-12-15 | Grais Linda Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2022-12-15 | CONWAY ROBERT E Director | Grant or award · Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2022-12-15 | Flynn James P Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2022-12-15 | Funicular Funds, LP 10% owner | Grant or award · Stock Option (right to buy) | +6,000 | 18,000 | ||
| 2022-12-08 | Keuer Thomas A Chief Operating Officer | Grant or award | +40,000 | 40,730 |
Page 16 of 18 · 346 trades